Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels

Immunol Lett. 2005 Apr 15;98(1):103-13. doi: 10.1016/j.imlet.2004.10.018. Epub 2004 Nov 24.

Abstract

The mechanisms whereby Vitamin A regulates the immune system are poorly understood. We have shown previously that retinoic acids, the Vitamin A derivatives, promote both apoptosis of neglected thymocytes and the activation-induced cell death of peripheral T-cells via ligating the nuclear retinoid receptor (RAR) gamma. In the present study, we found that human peripheral T-cells express RARalpha and gamma, but not RARbeta. Increasing concentrations of 9-cis RA inhibited phytohaemagglutinin (PHA)-induced proliferation of T-cells, an effect that could be mimicked only by addition of RARgamma agonists and could be inhibited by an RARgamma antagonist. Interleukin-2 (IL-2) produced is known to mediate PHA-induced proliferation of T lymphocytes. Ligation of RARgamma did not affect the PHA-induced high affinity IL-2 receptor expression, slightly reduced the PHA-induced IL-2 production, but interfered with the IL-2-mediated signal transduction resulting in inhibition of PHA-induced phosphorylation of retinoblastoma protein and of up-regulation of Bcl-2. Janus kinases JAK1 and JAK3 play a determinant role in IL-2-dependent signal transduction. Ligation of RARgamma did not affect the levels of JAK1, but prevented IL-2-induced expression of JAK3 resulting in inhibition of PHA-induced phosphorylation of Stat5 molecules. Our data suggest that the previously observed toxic effect of high concentrations of retinoids on the immune system might be mediated via formation of 9-cis RA, which via ligation of RARgamma not only induces cell death in immature thymocytes, but inhibits proliferation of T-cells as well.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alitretinoin
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cell Proliferation* / drug effects
  • DNA-Binding Proteins / metabolism
  • Down-Regulation
  • Humans
  • Interleukin-2 / metabolism
  • Janus Kinase 3
  • Milk Proteins / metabolism
  • Phosphorylation
  • Phytohemagglutinins / pharmacology
  • Protein-Tyrosine Kinases / metabolism*
  • Receptors, Retinoic Acid / metabolism*
  • Retinoic Acid Receptor gamma
  • STAT5 Transcription Factor
  • Signal Transduction / physiology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism*
  • Trans-Activators / metabolism
  • Tretinoin / pharmacology

Substances

  • Antineoplastic Agents
  • DNA-Binding Proteins
  • Interleukin-2
  • Milk Proteins
  • Phytohemagglutinins
  • Receptors, Retinoic Acid
  • STAT5 Transcription Factor
  • Trans-Activators
  • Alitretinoin
  • Tretinoin
  • Protein-Tyrosine Kinases
  • JAK3 protein, human
  • Janus Kinase 3